Submitted for Publication: September 5, 2014; final revision received December 29, 2014; accepted January 8, 2015.
Published Online: March 4, 2015. doi:10.1001/jamapsychiatry.2015.49.
Study concept and design: Ruzicka, Benes.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: All authors.
Critical revision of the manuscript for important intellectual content: Ruzicka, Benes.
Statistical analysis: Ruzicka.
Obtained funding: Ruzicka, Benes.
Administrative, technical, or material support: Subburaju, Benes.
Study supervision: Subburaju, Benes.
Conflict of Interest Disclosures: None reported.
Funding/Support: This work was supported by grants MH077175 (Dr Benes) and MH/NS 077550 (Dr Benes) from the National Institutes of Health and by the William P. and Henry B. Test Endowment from Harvard University (Dr Benes). Dr Ruzicka is supported by a Dupont-Warren Fellowship from Harvard Medical School, the MD/PhD Fellowship from the American Psychiatric Association and Pfizer Pharmaceuticals, a NARSAD Young Investigator Award from the Brain and Behavior Research Foundation, and the Andrew P. Merrill Memorial Research Fellowship and Maria Lorenz Pope Fellowship from McLean Hospital.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.